Automated microfluidic phage display through non fouling droplet based technolog...
Automated microfluidic phage display through non fouling droplet based technologies
Effective diagnostic technologies are essential for mitigating the devastating impact that infectious disease has on society. The identification of ligands that can target infectious disease biomarkers within patient samples is ke...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
INSTANTCOUNT
Printed microfluidic counting chambers for low cost point of...
1M€
Cerrado
PTQ-08-02-07267
Desarrollo de sistemas microfluídicos capilares aplicado a d...
64K€
Cerrado
BIOMEDMICROFLUIDICS
Modelling and Optimization of Microfluidic Devices for Biome...
100K€
Cerrado
DropChips
Droplet based chips for biologists
168K€
Cerrado
BrainChip
Human on Chip Microsensor unit and control algorithm integ...
82K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Effective diagnostic technologies are essential for mitigating the devastating impact that infectious disease has on society. The identification of ligands that can target infectious disease biomarkers within patient samples is key to the function of modern diagnostics. Unfortunately, current methods for ligand selection are slow and labour intensive, and frequently hinder the development of diagnostic technologies. Novel methods for automating this process will increase efficiency and improve the capacity of communities to respond to outbreaks and epidemics. During this fellowship I will develop a novel microfluidic device capable of automated high-throughput selection of highly robust infectious disease targeting ligands. The main objectives are as follows: 1) Explore novel microfluidic materials that are compatible with common ligand selection work flows; 2) Develop a fully automated microfluidic platform capable of performing multiple rounds of ligand selection; 3) Apply this system to generate novel ligands against an emerging HIV biomarker. The device will be underpinned by multiple core microfluidic technologies developed within the host lab, including: rapid droplet generation, droplet disruption, non-fouling materials, and highly responsive microvalves. These technologies will be combined with my expertise in protein chemistry, protein engineering, and chemical biology to achieve a significant leap forwards in automated ligand selection. The resultant device will vastly increase accessibility to high-throughput ligand selection, enabling smaller labs to more effectively select high-affinity ligands against emerging disease targets. This will have a significant impact on the fields of diagnostics, targeted therapeutics, protein engineering, and microfluidics.